A Phase 1 interventional study of XH02 mRNA therapy in hypoparathyroidism
Recruiting Early Phase 1 NCT07197450
Study Description
Testing a new mRNA-based treatment (XH02) to replace missing parathyroid hormone in people with hypoparathyroidism
Study Details
- Registry ID:
- NCT07197450
- Conditions:
- Hypoparathyroidism
- Phase:
- Early Phase 1
- Target Enrollment:
- 6 participants
- Start Date:
- Age Range:
- 18–65 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Peking Union Medical College Hospital
Beijing, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.